Baidu
map

和血明目片治疗湿性年龄相关性黄斑变性临床应用专家共识

2021-08-20 中华中医药学会眼科分会 中国中医眼科杂志

和血明目片上市20余年以来,在临床得到广泛应用,在治疗湿性年龄相关性黄斑变性所致眼底出血时,亦取得明显疗效,可改善患者眼部症状,提高视功能。

中文标题:

和血明目片治疗湿性年龄相关性黄斑变性临床应用专家共识

发布日期:

2021-08-20

简要介绍:

和血明目片上市20余年以来,在临床得到广泛应用,在治疗湿性年龄相关性黄斑变性所致眼底出血时,亦取得明显疗效,可改善患者眼部症状,提高视功能。但目前尚无相关规范指导和血明目片的临床应用,为了进一步提高广大临床医生对和血明目片治疗湿性年龄相关性黄斑变性的认识,更好指导临床规范、合理使用和血明目片,中华中医药学会眼科分会组织中西医眼科专家、药学专家及方法学专家成立项目组,按照《中华中医药学会中成药临床应用专家共识技术方案(试行)》的相关要求,充分考虑循证证据并借鉴专家临床经验,编制了《和血明目片治疗湿性年龄相关性黄斑变性临床应用专家共识》。

相关资料下载:
[AttachmentFileName(sort=1, fileName=和血明目片治疗湿性年龄相关性黄斑变性临床应用专家共识.pdf)] GetToolGuiderByIdResponse(projectId=1, id=e347c1c00225297b, title=和血明目片治疗湿性年龄相关性黄斑变性临床应用专家共识, enTitle=, guiderFrom=中国中医眼科杂志, authorId=0, author=, summary=和血明目片上市20余年以来,在临床得到广泛应用,在治疗湿性年龄相关性黄斑变性所致眼底出血时,亦取得明显疗效,可改善患者眼部症状,提高视功能。, cover=https://img.medsci.cn/2021114/1635955637821_1608702.jpg, journalId=0, articlesId=null, associationId=2096, associationName=中华中医药学会眼科分会, associationIntro=中华中医药学会眼科分会, copyright=0, guiderPublishedTime=Fri Aug 20 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #333333;">和血明目片上市20余年以来,在临床得到广泛应用,在治疗湿性年龄相关性黄斑变性所致眼底出血时,亦取得明显疗效,可改善患者眼部症状,提高视功能。但目前尚无相关规范指导和血明目片的临床应用,为了进一步提高广大临床医生对和血明目片治疗湿性年龄相关性黄斑变性的认识,更好指导临床规范、合理使用和血明目片,中华中医药学会眼科分会组织中西医眼科专家、药学专家及方法学专家成立项目组,按照《中华中医药学会中成药临床应用专家共识技术方案(试行)》的相关要求,充分考虑循证证据并借鉴专家临床经验,编制了《和血明目片治疗湿性年龄相关性黄斑变性临床应用专家共识》。</span></p>, tagList=[TagDto(tagId=99610, tagName=湿性年龄相关性黄斑变性)], categoryList=[CategoryDto(categoryId=32, categoryName=眼科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=99610, guiderKeyword=湿性年龄相关性黄斑变性, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4644, appHits=137, showAppHits=0, pcHits=501, showPcHits=4507, likes=0, shares=9, comments=12, approvalStatus=1, publishedTime=Tue Nov 16 23:56:36 CST 2021, publishedTimeString=2021-08-20, pcVisible=1, appVisible=1, editorId=1608702, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=4, createdBy=null, createdName=dajiong, createdTime=Thu Nov 04 00:10:53 CST 2021, updatedBy=4754896, updatedName=小小医者, updatedTime=Fri Jan 05 13:59:49 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=和血明目片治疗湿性年龄相关性黄斑变性临床应用专家共识.pdf)])
和血明目片治疗湿性年龄相关性黄斑变性临床应用专家共识.pdf
下载请点击:
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1207287, encodeId=ff3f120e28783, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a9c3997331, createdName=139ef189m47暂无昵称, createdTime=Wed Mar 30 18:44:35 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189602, encodeId=d4a711896029a, content=内容不错<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3fa6482137, createdName=ms9000001995137444, createdTime=Tue Feb 01 21:46:57 CST 2022, time=2022-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085314, encodeId=377810853143b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df876430416, createdName=ms2000001556510080, createdTime=Wed Dec 29 08:17:01 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075982, encodeId=0e8410e59821f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211121/9ea295fa6f1141baaf5cca7484a33164/749e6341395641abb4881b33ae5e9d68.jpg, createdBy=484e5725266, createdName=spiritnsy, createdTime=Wed Dec 01 20:34:04 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074802, encodeId=2dfa10e480242, content=学习哈, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4396151100, createdName=ms4000001442603092, createdTime=Sun Nov 28 16:53:01 CST 2021, time=2021-11-28, status=1, ipAttribution=)]
    2022-03-30 139ef189m47暂无昵称

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1207287, encodeId=ff3f120e28783, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a9c3997331, createdName=139ef189m47暂无昵称, createdTime=Wed Mar 30 18:44:35 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189602, encodeId=d4a711896029a, content=内容不错<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3fa6482137, createdName=ms9000001995137444, createdTime=Tue Feb 01 21:46:57 CST 2022, time=2022-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085314, encodeId=377810853143b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df876430416, createdName=ms2000001556510080, createdTime=Wed Dec 29 08:17:01 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075982, encodeId=0e8410e59821f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211121/9ea295fa6f1141baaf5cca7484a33164/749e6341395641abb4881b33ae5e9d68.jpg, createdBy=484e5725266, createdName=spiritnsy, createdTime=Wed Dec 01 20:34:04 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074802, encodeId=2dfa10e480242, content=学习哈, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4396151100, createdName=ms4000001442603092, createdTime=Sun Nov 28 16:53:01 CST 2021, time=2021-11-28, status=1, ipAttribution=)]
    2022-02-01 ms9000001995137444

    内容不错#学习#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1207287, encodeId=ff3f120e28783, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a9c3997331, createdName=139ef189m47暂无昵称, createdTime=Wed Mar 30 18:44:35 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189602, encodeId=d4a711896029a, content=内容不错<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3fa6482137, createdName=ms9000001995137444, createdTime=Tue Feb 01 21:46:57 CST 2022, time=2022-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085314, encodeId=377810853143b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df876430416, createdName=ms2000001556510080, createdTime=Wed Dec 29 08:17:01 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075982, encodeId=0e8410e59821f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211121/9ea295fa6f1141baaf5cca7484a33164/749e6341395641abb4881b33ae5e9d68.jpg, createdBy=484e5725266, createdName=spiritnsy, createdTime=Wed Dec 01 20:34:04 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074802, encodeId=2dfa10e480242, content=学习哈, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4396151100, createdName=ms4000001442603092, createdTime=Sun Nov 28 16:53:01 CST 2021, time=2021-11-28, status=1, ipAttribution=)]
    2021-12-29 ms2000001556510080

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1207287, encodeId=ff3f120e28783, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a9c3997331, createdName=139ef189m47暂无昵称, createdTime=Wed Mar 30 18:44:35 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189602, encodeId=d4a711896029a, content=内容不错<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3fa6482137, createdName=ms9000001995137444, createdTime=Tue Feb 01 21:46:57 CST 2022, time=2022-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085314, encodeId=377810853143b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df876430416, createdName=ms2000001556510080, createdTime=Wed Dec 29 08:17:01 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075982, encodeId=0e8410e59821f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211121/9ea295fa6f1141baaf5cca7484a33164/749e6341395641abb4881b33ae5e9d68.jpg, createdBy=484e5725266, createdName=spiritnsy, createdTime=Wed Dec 01 20:34:04 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074802, encodeId=2dfa10e480242, content=学习哈, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4396151100, createdName=ms4000001442603092, createdTime=Sun Nov 28 16:53:01 CST 2021, time=2021-11-28, status=1, ipAttribution=)]
    2021-12-01 spiritnsy

    学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1207287, encodeId=ff3f120e28783, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a9c3997331, createdName=139ef189m47暂无昵称, createdTime=Wed Mar 30 18:44:35 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189602, encodeId=d4a711896029a, content=内容不错<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3fa6482137, createdName=ms9000001995137444, createdTime=Tue Feb 01 21:46:57 CST 2022, time=2022-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085314, encodeId=377810853143b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df876430416, createdName=ms2000001556510080, createdTime=Wed Dec 29 08:17:01 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075982, encodeId=0e8410e59821f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211121/9ea295fa6f1141baaf5cca7484a33164/749e6341395641abb4881b33ae5e9d68.jpg, createdBy=484e5725266, createdName=spiritnsy, createdTime=Wed Dec 01 20:34:04 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074802, encodeId=2dfa10e480242, content=学习哈, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4396151100, createdName=ms4000001442603092, createdTime=Sun Nov 28 16:53:01 CST 2021, time=2021-11-28, status=1, ipAttribution=)]
    2021-11-28 ms4000001442603092

    学习哈

    0

拓展阅读

2024 NICE 技术鉴定指南:贝伐单抗γ治疗湿性年龄相关性黄斑变性 [TA1022]

英国国家卫生与临床优化研究所(NICE,National Institute for Health and Clinical Excellence) · 2024-12-04

Baidu
map
Baidu
map
Baidu
map